A clinical trial involving people with type one diabetes is showing promising results that could move some patients closer to living without insulin injections.Researchers are studying islet cell transplantation, a procedure that replaces insulin-producing cells destroyed by type one diabetes. Early results from a trial led by Eledon Pharmaceuticals suggest a new approach to preventing transplant rejection may improve outcomes for patients.The r…